美国《生物安全法案》出台后，瑞士Rockets收购华大智造子公司Complete Genomics
The Chinese DNA sequencing company MGI has sold its US subsidiary Complete Genomics, following a legislative crackdown that blunted its expansion plans.
Swiss-based life sciences company Swiss Rockets will buy Complete Genomics, and in the ...
⚠️ 风险分析 高
摘要：受美国《生物安全法案》影响，华大智造被迫出售其美国子公司Complete Genomics。
影响：中国生物科技企业在美业务因监管压力被迫收缩，面临市场准入和资产剥离风险，直接影响其全球战略布局。
建议：评估在美资产与供应链的合规风险，考虑业务重组或寻找非敏感市场合作伙伴，以规避类似监管冲击。
「素履以往」
Not the sharpest mind, but the steadiest hand.
Not the sharpest mind, but the steadiest hand.